Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dysphoric mania.

J Clothier1, A C Swann, T Freeman

  • 1Department of Psychiatry and Behavioral Sciences, University of Arkansas Medical School, Little Rock 72205-7199.

Journal of Clinical Psychopharmacology
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding traumatic injuries and suicide risk: A conceptual exploration for the emergency department.

Journal of affective disorders·2025
Same author

A population-centered model for public health medicine.

Public health·2024
Same author

Emotional self-regulation, impulsivity, 5-HTTLPR and tobacco use behavior among psychiatric inpatients.

Journal of affective disorders·2022
Same author

A comparison of the characteristics, motivations, preferences and expectations of men donating sperm online or through a sperm bank.

Human reproduction (Oxford, England)·2019
Same author

Equine gestational length and location: is there more that the research could be telling us?

Australian veterinary journal·2017
Same author

Do Hospital Boards matter for better, safer, patient care?

Social science & medicine (1982)·2017
Same journal

Aripiprazole Withdrawal-Associated Restless Legs Syndrome During Clozapine Treatment in an Adolescent With Schizoaffective Disorder: A Case Report.

Journal of clinical psychopharmacology·2026
Same journal

Salute to Our Reviewers.

Journal of clinical psychopharmacology·2026
Same journal

Article Selected to Receive the Mitchell B. Balter Award for Publications in 2025.

Journal of clinical psychopharmacology·2026
Same journal

Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine: Prospective Outcomes From the MGH National Pregnancy Registry for Psychiatric Medications.

Journal of clinical psychopharmacology·2026
Same journal

Salute to Our Reviewers.

Journal of clinical psychopharmacology·2026
Same journal

Serotonin Syndrome Associated With Polypharmacy in an Elderly Patient With Dementia and Parkinson Disease.

Journal of clinical psychopharmacology·2026
See all related articles

Lithium is a common bipolar disorder treatment, but valproate may be better for patients with higher depression scores. Mixed states showed equal response to both lithium and valproate.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Neuroscience

Background:

  • Lithium is a primary treatment for bipolar disorder.
  • Patients with mixed states or dysphoria often respond poorly to lithium.
  • Predicting treatment response based on illness characteristics is crucial.

Purpose of the Study:

  • To compare lithium and valproate efficacy in bipolar mania.
  • To identify predictors of positive response to lithium or valproate.

Main Methods:

  • Double-blind, parallel-group study.
  • 27 patients with bipolar disorder.
  • Comparison of lithium versus valproate for mania control.

Main Results:

  • Valproate responders had higher pretreatment depression scores than nonresponders.

Related Experiment Videos

  • Patients with depressed mood/anxiety in mixed states responded similarly to lithium and valproate.
  • Significant differences observed between valproate responders and nonresponders.
  • Conclusions:

    • Higher depression scores may predict valproate response in bipolar disorder.
    • Lithium and valproate show comparable efficacy for mixed states with depressed mood or anxiety.
    • Further research is needed to clarify mixed/dysphoric states and validate treatment predictors.